Faith healing |
|
|
Clinical Trial: Healing Touch and Relaxation Therapies in Cervical Cancer Patients
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to evaluate the effects of healing touch and relaxation therapy on cervical cancer patients undergoing chemotherapy and radiation treatment.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cervix Neoplasms | Behavior: Healing Touch Therapy Behavior: Relaxation Therapy | Phase II |
MedlinePlus related topics: Cervical Cancer
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Healing Touch in Advanced Cervical Cancer Patients: Immune Effects and Mechanisms
Expected Total Enrollment: 70
Study start: September 2002; Expected completion: May 2005
The side effects of chemotherapy and radiation treatment are often severe and can have devastating effects on the mental and physical well-being of cancer patients. This study will determine whether healing touch and relaxation therapy are effective in minimizing the side effects of chemotherapy and radiation treatment in cervical cancer patients.
Participants in this study will receive weekly chemotherapy and daily radiation treatments for 6 weeks. Participants will be randomly assigned to receive either standard care (SC), SC plus relaxation therapy, or SC plus healing touch therapy. The relaxation therapy consists of progressive muscle relaxation and guided imagery. The healing touch therapy involves an energy-based modality in which health care practitioners stimulate the energy fields surrounding the patient. A physician-completed assessment and measures of immune function will be used to assess the well-being and overall quality of life of participants.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Stage I-IV cervical cancer
- Treatment with concurrent chemotherapy and radiation at the University of Iowa Hospitals and Clinics
Exclusion Criteria:
- Immunosuppressive disorders
- Use of immunosuppressive medications
- Transplant recipient
- Metastatic or recurrent cervical cancer
- History of any other type of cancer
Location and Contact Information
Iowa
University of Iowa Hospital and Clinics, Iowa City, Iowa, 52242, United States; Recruiting
Susan K. Lutgendorf, PhD, Principal Investigator
More Information
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: June 7, 2004
ClinicalTrials.gov Identifier: NCT00084123
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Faith healing (Wikipedia)

Not Signed In -

